Galbanic acid inhibits HIF-1α expression via EGFR/HIF-1α pathway in cancer cells

Fitoterapia

Volumn 101, Issue , 2015, Pages 1-11

  Eskandani, Morteza ^a,b   Abdolalizadeh, Jalal ^b   Hamishehkar, Hamed ^c   Nazemiyeh, Hossein ^a,b   Barar, Jaleh ^a,b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cancer; EGFR; Enolase; Galbanic acid (GBA); GluT 1; HIF 1 ; Hypoxia inducible factor 1 (HIF 1)

Indexed keywords

ENOLASE; ENOLASE 1; EPIDERMAL GROWTH FACTOR RECEPTOR; GALBANIC ACID; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; MESSENGER RNA; PHOSPHATIDYLSERINE; PROTEIN INHIBITOR; PROTEIN KINASE B; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; COUMARIN DERIVATIVE; EGFR PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL MEMBRANE; CELL METABOLISM; CELL VIABILITY; CHEMICAL STRUCTURE; CYTOTOXICITY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GLYCOLYSIS; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; OVARIAN CANCER CELL LINE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN SYNTHESIS INHIBITION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR GROWTH; TUMOR VASCULARIZATION; CELL HYPOXIA; CELL SURVIVAL; GENE EXPRESSION REGULATION; METABOLISM; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL HYPOXIA; CELL LINE, TUMOR; CELL SURVIVAL; COUMARINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84919906650     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2014.12.003     Document Type: Article

References (51)

1. (WHO). W.H.O., the top 10 causes of death. Switzerland: WHO; 2014.
2. Wilson WR, Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer 2011;11:393-410.
3. Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 2004;4:437-47.
4. Semenza GL. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 2002;8:S62-7.
5. Jiang BH, Rue E, Wang GL, Roe R, Semenza GL. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 1996;271:17771-8.
6. Poon E, Harris AL, Ashcroft M. Targeting the hypoxia-inducible factor (HIF) pathway in cancer. Expert Rev Mol Med 2009;11:e26.
7. Wang GL, Semenza GL. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A 1993;90: 4304-8.
8. Zagzag D, Lukyanov Y, Lan L, Ali MA, Esencay M, Mendez O, et al. Hypoxiainducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Invest 2006;86:1221-32.
9. Semenza GL. Oxygen sensing, homeostasis, and disease reply. N Engl J Med 2011;365:1846.
10. Erler JT, Giaccia AJ. Lysyl oxidase mediates hypoxic control of metastasis. Cancer Res 2006;66:10238-41.
11. Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT, et al. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 2006;440:1222-6.
12. McMullin MF. HIF pathway mutations and erythrocytosis. Expert Rev Hematol 2010;3:93-101.
13. Mikrogianakis A, Shaye RE, Griffin P, Kawesa S, Lockwood J, Gendron NH, et al. Hypoxia alters the expression of inhibitor of apoptosis proteins after brain trauma in the mouse. J Neurotrauma 2007;24:338-53.
14. Rockwell S, Dobrucki IT, Kim EY, Marrison ST, Vu VT. Hypoxia and radiation therapy: past history, ongoing research, and future promise. Curr Mol Med 2009;9:442-58.
15. Nagle DG, Zhou YD. Natural product-based inhibitors of hypoxia-inducible factor-1 (HIF-1). Curr Drug Targets 2006;7:355-69.
16. Nagle DG, Zhou YD. Marine natural products as inhibitors of hypoxic signaling in tumors. Phytochem Rev 2009;8:415-29.
17. Manolescu B, Oprea E, Busu C, Cercasov C. Natural compounds and the hypoxia-inducible factor (HIF) signalling pathway. Biochimie 2009;91:1347-58.
18. Bedniak AE. On the problem of the isolation of galbanic acid from Ferula gumosa Boiss. roots. Aptechn Delo 1962;12:28-34.
19. Abd El-Razek MH, Ohta S, Ahmed AA, Hirata T. Sesquiterpene coumarins from the roots of Ferula assa-foetida. Phytochemistry 2001;58:1289-95.
20. Iranshahi M, Arfa P, Ramezani M, Jaafari MR, Sadeghian H, Bassarello C, et al. Sesquiterpene coumarins from Ferula szowitsiana and in vitro antileishmanial activity of 7-prenyloxycoumarins against promastigotes. Phytochemistry 2007;68:554-61.
21. Hanafi-Bojd MY, Iranshahi M, Mosaffa F, Tehrani SO, Kalalinia F, Behravan J. Farnesiferol A from Ferula persica and galbanic acid from Ferula szowitsiana inhibit P-glycoprotein-mediated rhodamine efflux in breast cancer cell lines. Planta Med 2011;77:1590-3.
22. Fazly Bazzaz BS, Iranshahi M, Naderinasab M, Hajian S, Sabeti Z, Masumi E. Evaluation of the effects of galbanic acid from Ferula szowitsiana and conferol from F. badrakema, as modulators of multi-drug resistance in clinical isolates of Escherichia coli and Staphylococcus aureus. Res Pharm Sci 2010;5:21-8.
23. Kohno S, Murata T, Sugiura A, Ito C, Iranshahi M, Hikita K, et al. Methyl galbanate, a novel inhibitor of nitric oxide production in mouse macrophage RAW264.7 cells. J Nat Med 2011;65:353-9.
24. Chen B, Teranishi R, Kawazoe K, Takaishi Y, Honda G, Itoh M, et al. Sesquiterpenoids from Ferula kuhistanica. Phytochemistry 2000;54:717-22.
25. Syrov VN, Khushbaktova ZA, Nabiev AN. The effect of galbanic acid on the course of experimental hepatitis. Farmakol Toksikol 1990;53:41-3.
26. Cha MR, Choi YH, Choi CW, Kim YS, Kim YK, Ryu SY, et al. Galbanic acid, a cytotoxic sesquiterpene from the gum resin of Ferula asafoetida, blocks protein farnesyltransferase. Planta Med 2011;77:52-4.
27. Zhang Y, Kim KH, Zhang W, Guo Y, Kim SH, Lu J. Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells. Int J Cancer 2012;130:200-12.
28. Mozaffarian V. The family of umbelliferae in Iran - keys and distribution. Tehran: Research Institute of Forests and Rangelands Press; 1983.
29. Eskandani M, Barar J, Ezzati Nazhad Dolatabadi J, Hamishehkar H, Nazemiyeh H. Formulation, characterization and geno/cytotoxicity studies of galbanic acid-loaded solid lipid nanoparticles. Pharm Biol 2015. http://dx.doi.org/10.3109/13880209.2014.991836.
30. Shahverdi AR, Fakhimi A, Zarrini G, Dehghan G, Iranshahi M. Galbanic acid from Ferula szowitsiana enhanced the antibacterial activity of penicillin G and cephalexin against Staphylococcus aureus. Biol Pharm Bull 2007;30:1805-7.
31. Mansurov MM, Martirosov MS. The action of the sodium salt of galbanic acid in experimental erythrocyte hyperaggregation. Farmakol Toksikol 1990;53:51-3.
32. Kim KH, Lee HJ, Jeong SJ, Lee EO, Kim HS, Zhang Y, et al. Galbanic acid isolated from Ferula assafoetida exerts in vivo anti-tumor activity in association with anti-angiogenesis and anti-proliferation. Pharm Res 2011;28:597-609.
33. Delazar A, Biglari F, Esnaashari S, Nazemiyeh H, Talebpour AH, Nahar L, et al. GC-MS analysis of the essential oils, and the isolation of phenylpropanoid derivatives from the aerial parts of Pimpinella aurea. Phytochemistry 2006;67:2176-81.
34. Wu D, Yotnda P. Induction and testing of hypoxia in cell culture. J Vis Exp 2011;54:e2899. http://dx.doi.org/10.3791/2899.
35. Eskandani M, Hamishehkar H, Ezzati Nazhad Dolatabadi J. Cytotoxicity and DNA damage properties of tert-butylhydroquinone (TBHQ) food additive. Food Chem 2014;153:315-20.
36. Eskandani M, Hamishehkar H, Ezzati Nazhad Dolatabadi J. Cyto/genotoxicity study of polyoxyethylene (20) sorbitan monolaurate (tween 20). DNA Cell Biol 2013;32:498-503.
37. Eskandani M, Nazemiyeh H. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation. Eur J Pharm Sci 2014;59:49-57.
38. Vandghanooni S, Eskandani M, Montazeri V, Halimi M, Babaei E, Feizi MA. Survivin-deltaEx3: a novel biomarker for diagnosis of papillary thyroid carcinoma. J Cancer Res Ther 2011;7:325-30.
39. Pfaffl MW. A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res 2001;29:e45.
40. Atanasov AG, Ignatova ID, Nashev LG, Dick B, Ferrari P, Frey FJ, et al. Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess. J Am Soc Nephrol 2007;18:1262-70.
41. Liu L-Z, Jing Y, Jiang LL, Jiang X-E, Jiang Y, Rojanasakul Y, et al. Acacetin inhibits VEGF expression, tumor angiogenesis and growth through AKT/HIF-1α pathway. Biochem Biophys Res Commun 2011;413:299-305.
42. Bhat S, Nagusampag B, Kumar M. Chemistry of natural products. New delhi: Narosa; 2006.
43. Murray RDH, Mondez J, Brown SA. Chemistry and biochemistry. Bristol: Wiley; 1982.
44. Corbu A, Aquino M, Perez M, Gandara Z, Arseniyadis S. Natural and unnatural a-seco terpenes from pulegone: synthesis of galbanic acid and marneral revisited. Eur J Org Chem 2009;2009:6386-92.
45. Formenti F, Constantin-Teodosiu D, Emmanuel Y, Cheeseman J, Dorrington KL, Edwards LM, et al. Regulation of human metabolism by hypoxia-inducible factor. Proc Natl Acad Sci U S A 2010;107:12722-7.
46. Chan DA, Sutphin PD, Yen SE, Giaccia AJ. Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha. Mol Cell Biol 2005;25:6415-26.
47. Pore N, Jiang Z, Gupta A, Cerniglia G, Kao GD, Maity A. EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms. Cancer Res 2006;66:3197-204.
48. Eccles SA. The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology. Int J Dev Biol 2011;55:685-96.
49. Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007;26:3291-310.
50. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3:721-32.
51. Kasaian J, Iranshahy M, Iranshahi M. Synthesis, biosynthesis and biological activities of galbanic acid - a review. Pharm Biol 2014;52:524-31.